ACC Issues Clinical Guidance on ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia – American College of Cardiology

A new ACC Expert Consensus Decision Pathway aims to fill the gap in clinical care for the management of high-risk atherosclerotic cardiovascular disease (ASCVD) patients with persistent hypertriglyceridemia and the incorporation of triglyceride nonstatin therapies. The 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent…

Read the full article here

Related Articles